AP998A - Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation. - Google Patents

Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation. Download PDF

Info

Publication number
AP998A
AP998A APAP/P/1999/001530A AP9901530A AP998A AP 998 A AP998 A AP 998A AP 9901530 A AP9901530 A AP 9901530A AP 998 A AP998 A AP 998A
Authority
AP
ARIPO
Prior art keywords
dalfopristine
quinupristine
pharmaceutical composition
solution
composition according
Prior art date
Application number
APAP/P/1999/001530A
Other languages
English (en)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of AP998A publication Critical patent/AP998A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1999/001530A 1996-11-19 1997-11-14 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation. AP998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (1)

Publication Number Publication Date
AP998A true AP998A (en) 2001-08-09

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1999/001530A AP998A (en) 1996-11-19 1997-11-14 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation.

Country Status (45)

Country Link
US (1) US5994338A (es)
EP (1) EP0949923B1 (es)
JP (1) JP4278115B2 (es)
KR (1) KR100530836B1 (es)
CN (1) CN1146417C (es)
AP (1) AP998A (es)
AR (1) AR008695A1 (es)
AT (1) ATE223217T1 (es)
AU (1) AU740291B2 (es)
BG (1) BG63621B1 (es)
BR (1) BR9713087A (es)
CA (1) CA2271095C (es)
CO (1) CO4910113A1 (es)
CZ (1) CZ299913B6 (es)
DE (1) DE69715247T2 (es)
DK (1) DK0949923T3 (es)
DZ (1) DZ2349A1 (es)
EA (1) EA002025B1 (es)
EE (1) EE03668B1 (es)
ES (1) ES2179375T3 (es)
FR (1) FR2755857B1 (es)
HK (1) HK1022832A1 (es)
HR (1) HRP970615B1 (es)
HU (1) HUP9904327A3 (es)
IL (2) IL129607A0 (es)
IN (1) IN187038B (es)
JO (1) JO1992B1 (es)
MA (1) MA26448A1 (es)
MY (1) MY123805A (es)
NO (1) NO992399L (es)
NZ (1) NZ334949A (es)
OA (1) OA11047A (es)
PE (1) PE13999A1 (es)
PL (1) PL190164B1 (es)
PT (1) PT949923E (es)
RS (1) RS49608B (es)
SA (1) SA97180645B1 (es)
SK (1) SK284311B6 (es)
TN (1) TNSN97184A1 (es)
TR (1) TR199901096T2 (es)
TW (1) TW474816B (es)
UA (1) UA59376C2 (es)
UY (1) UY24780A1 (es)
WO (1) WO1998022107A1 (es)
ZA (1) ZA9710435B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
PT1115417E (pt) * 1998-09-25 2006-07-31 Cubist Pharm Inc Utilizacao da daptomicina
ES2433678T3 (es) * 1999-03-03 2013-12-12 Eli Lilly & Company Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135410A1 (fr) * 1983-07-13 1985-03-27 Rhone-Poulenc Sante Dérivés de synergistines, leur préparation et les compositions pharmaceutiques qui les contiennent
EP0248703A1 (fr) * 1986-05-22 1987-12-09 Aventis Pharma S.A. Nouveaux dérivés de synergistines, leur préparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135410A1 (fr) * 1983-07-13 1985-03-27 Rhone-Poulenc Sante Dérivés de synergistines, leur préparation et les compositions pharmaceutiques qui les contiennent
EP0248703A1 (fr) * 1986-05-22 1987-12-09 Aventis Pharma S.A. Nouveaux dérivés de synergistines, leur préparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HRP970615A2 (en) 1998-08-31
HUP9904327A2 (hu) 2000-06-28
BG103412A (en) 2000-06-30
EA199900479A1 (ru) 2000-02-28
TW474816B (en) 2002-02-01
HUP9904327A3 (en) 2002-03-28
ES2179375T3 (es) 2003-01-16
WO1998022107A1 (fr) 1998-05-28
IN187038B (es) 2001-12-29
CA2271095A1 (fr) 1998-05-28
DE69715247D1 (de) 2002-10-10
AU5125698A (en) 1998-06-10
DK0949923T3 (da) 2002-12-23
SK284311B6 (sk) 2005-01-03
CN1146417C (zh) 2004-04-21
EP0949923B1 (fr) 2002-09-04
JO1992B1 (en) 1999-05-15
DZ2349A1 (fr) 2002-12-28
RS49608B (sr) 2007-06-04
NZ334949A (en) 2000-12-22
BG63621B1 (bg) 2002-07-31
CN1233959A (zh) 1999-11-03
TNSN97184A1 (fr) 2005-03-15
PL190164B1 (pl) 2005-11-30
PE13999A1 (es) 1999-05-05
HRP970615B1 (en) 2002-12-31
JP4278115B2 (ja) 2009-06-10
NO992399D0 (no) 1999-05-19
UY24780A1 (es) 2001-08-27
HK1022832A1 (en) 2000-08-25
CZ174899A3 (cs) 1999-08-11
EE9900127A (et) 1999-12-15
AU740291B2 (en) 2001-11-01
TR199901096T2 (xx) 1999-07-21
KR100530836B1 (ko) 2005-11-23
KR20000053343A (ko) 2000-08-25
SK66099A3 (en) 2000-01-18
PT949923E (pt) 2003-01-31
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
MY123805A (en) 2006-06-30
EE03668B1 (et) 2002-04-15
OA11047A (fr) 2003-03-07
US5994338A (en) 1999-11-30
ATE223217T1 (de) 2002-09-15
IL129607A0 (en) 2000-02-29
CA2271095C (fr) 2004-08-03
IL129607A (en) 2006-08-20
JP2001504475A (ja) 2001-04-03
EA002025B1 (ru) 2001-12-24
AR008695A1 (es) 2000-02-09
DE69715247T2 (de) 2003-04-30
YU22499A (sh) 2002-03-18
EP0949923A1 (fr) 1999-10-20
BR9713087A (pt) 2000-03-28
ZA9710435B (en) 1998-06-10
MA26448A1 (fr) 2004-12-20
FR2755857B1 (fr) 1998-12-24
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
NO992399L (no) 1999-05-19
CZ299913B6 (cs) 2008-12-29

Similar Documents

Publication Publication Date Title
TWI296523B (en) Formulations
CA2140347C (en) Injection and injection kit containing omeprazole and its analogs
US6780881B2 (en) Freeze-dried pantoprazole preparation and pantoprazole injection
JP7229999B2 (ja) ダプトマイシン製剤
JP6182262B2 (ja) 抗がん剤を含む安定な水溶性医薬組成物
AP998A (en) Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation.
JP2007500191A (ja) Ｃｃｉ−７７９の凍結乾燥処方
JP4142149B2 (ja) バンコマイシンの凍結乾燥製剤
RU2315623C2 (ru) Жидкий препарат, содержащий производное кампототецина, и фармацевтическая композиция, получаемая путем лиофилизации препарата
JP2016521732A (ja) 安定な抗がん剤のアルギニン塩とそれを含む組成物
JP4326148B2 (ja) ダルホプリスチンおよびキヌプリスチンに基づく医薬組成物ならびに調製
US20060252804A1 (en) Flupirtin injectable galenic form
JP2022185009A (ja) 安定したアザシチジン含有医薬組成物の製造方法
EP1039905B1 (en) Pharmaceutical formulation comprising glycine as a stabilizer
JP2536173B2 (ja) 注射剤
US20020177611A1 (en) Pharmaceutical formulation comprising glycine as a stabilizer
US10576088B2 (en) Compositions comprising finafloxacin and Tris
RU2095061C1 (ru) Фармацевтическая композиция
US6187746B1 (en) Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US20140275122A1 (en) Voriconazole Formulations
US20090137633A1 (en) Stable pharmaceutical composition of rabeprazole